ATE60999T1 - Dimethyldioctadecylammoniumbromid enthaltende stabilisierte adjuvanssuspension. - Google Patents

Dimethyldioctadecylammoniumbromid enthaltende stabilisierte adjuvanssuspension.

Info

Publication number: ATE60999T1
Authority: AT; Austria
Prior art keywords: stabilized; suspension containing; dimethyldioctadecylammonium bromide; adjuvant; adjuvant suspension
Prior art date: 1986-12-19

Application number

AT87202523T

Other languages

English (en)

Inventor

Lucas Alfonsus Theodor Hilgers

Marinus Wijnand Weststrate

Original Assignee

Duphar Int Res

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-12-19

Filing date

1987-12-15

Publication date

1991-03-15

1987-12-15 Application filed by Duphar Int Res filed Critical Duphar Int Res

1991-03-15 Application granted granted Critical

1991-03-15 Publication of ATE60999T1 publication Critical patent/ATE60999T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Mycology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Sorption Type Refrigeration Machines (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Liquid Crystal Substances (AREA)
Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Pyrrole Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)

AT87202523T 1986-12-19 1987-12-15 Dimethyldioctadecylammoniumbromid enthaltende stabilisierte adjuvanssuspension. ATE60999T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
NL8603232		1986-12-19
EP87202523A EP0273512B1 (de)	1986-12-19	1987-12-15	Dimethyldioctadecylammoniumbromid enthaltende stabilisierte Adjuvanssuspension

Publications (1)

Publication Number	Publication Date
ATE60999T1 true ATE60999T1 (de)	1991-03-15

Family

ID=19849021

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT87202523T ATE60999T1 (de)	1986-12-19	1987-12-15	Dimethyldioctadecylammoniumbromid enthaltende stabilisierte adjuvanssuspension.

Country Status (11)

Country	Link
US (1)	US5026546A (de)
EP (1)	EP0273512B1 (de)
JP (1)	JPS63165329A (de)
AT (1)	ATE60999T1 (de)
DE (1)	DE3768232D1 (de)
DK (1)	DK661387A (de)
ES (1)	ES2037072T3 (de)
GR (1)	GR3001527T3 (de)
IE (1)	IE60698B1 (de)
NZ (1)	NZ222938A (de)
PT (1)	PT86376B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0432431B1 (de) *	1989-11-16	1993-06-16	PHIDEA S.p.A.	Flüssige Arzneimittel zur nasalen Anwendung, die ein Polypeptid als Wirksubstanz enthalten
NZ239643A (en) *	1990-09-17	1996-05-28	North American Vaccine Inc	Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
IL105325A (en) *	1992-04-16	1996-11-14	Minnesota Mining & Mfg	Immunogen/vaccine adjuvant composition
US5955077A (en) *	1993-07-02	1999-09-21	Statens Seruminstitut	Tuberculosis vaccine
US6991797B2 (en) *	1993-07-02	2006-01-31	Statens Serum Institut	M. tuberculosis antigens
BE1008977A5 (fr) *	1994-12-27	1996-10-01	Solvay	Adjuvants pour vaccins.
US6982085B2 (en) *	1997-04-02	2006-01-03	Statens Serum Institut	TB diagnostic based on antigens from M. tuberculosis
US7037510B2 (en)	1997-04-18	2006-05-02	Statens Serum Institut	Hybrids of M. tuberculosis antigens
US20040013685A1 (en) *	1997-11-10	2004-01-22	Peter Andersen	Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis
FR2814957B1 (fr) *	2000-10-06	2002-12-20	Aventis Pasteur	Composition vaccinale et procede de stabilisation
NZ538394A (en) *	2002-08-26	2008-06-30	Pfizer Prod Inc	Vaccine for respiratory and reproductive system infections in cattles
US6962608B1 (en)	2002-10-01	2005-11-08	The Regents Of The University Of California	Regenerable antimicrobial polymers and fibers with oxygen bleaches
ES2391770T3 (es)	2003-01-21	2012-11-29	Novartis Vaccines And Diagnostics, Inc.	Uso de compuestos de triptantrina para la potenciación inmune
US7893096B2 (en)	2003-03-28	2011-02-22	Novartis Vaccines And Diagnostics, Inc.	Use of small molecule compounds for immunopotentiation
WO2006115509A2 (en)	2004-06-24	2006-11-02	Novartis Vaccines And Diagnostics Inc.	Small molecule immunopotentiators and assays for their detection
EP1765313A2 (de)	2004-06-24	2007-03-28	Novartis Vaccines and Diagnostics, Inc.	Verbindungen als immunstimulatoren
US7749520B2 (en) *	2004-07-07	2010-07-06	Statens Serum Institut	Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids
ITBO20050363A1 (it) *	2005-05-26	2006-11-27	Maccaferri Spa Off	Elemento leggero di protezione filtro del tipo a materasso
US20100010217A1 (en) *	2006-03-23	2010-01-14	Valiante Nicholas M	Methods for the preparation of imidazole-containing compounds
WO2007109812A2 (en) *	2006-03-23	2007-09-27	Novartis Ag	Immunopotentiating compounds
ES2536426T3 (es) *	2006-03-23	2015-05-25	Novartis Ag	Compuestos de imidazoquinoxalina como inmunomoduladores
CL2008001806A1 (es) *	2007-06-20	2008-09-05	Wyeth Corp	Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion.
WO2009156960A2 (en)	2008-06-27	2009-12-30	Pfizer Inc.	Novel adjuvant compositions
CA2745295C (en)	2008-12-09	2017-01-10	Gilead Sciences, Inc.	Modulators of toll-like receptors
JP6586083B2 (ja)	2013-09-19	2019-10-02	ゾエティス・サービシーズ・エルエルシー	油性アジュバント
WO2016001907A1 (en)	2014-07-02	2016-01-07	Prendergast Patrick T	Mogroside iv and mogroside v as agonist/stimulator/un-blocking agent for toll-like receptor 4 and adjuvant for use in human/animal vaccine and to stimulate immunity against disease agents.
CN107106674A (zh)	2015-01-16	2017-08-29	硕腾服务有限责任公司	口蹄疫疫苗
CN112512590A (zh) *	2018-06-04	2021-03-16	阿普罗斯治疗公司	Tlr7肽缀合物
US11364253B2 (en)	2018-07-02	2022-06-21	Ayuvis Research, Inc.	Immunodulating small molecules

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3919411A (en) *	1972-01-31	1975-11-11	Bayvet Corp	Injectable adjuvant and compositions including such adjuvant

1987
- 1987-12-15 ES ES198787202523T patent/ES2037072T3/es not_active Expired - Lifetime
- 1987-12-15 DE DE8787202523T patent/DE3768232D1/de not_active Expired - Fee Related
- 1987-12-15 AT AT87202523T patent/ATE60999T1/de not_active IP Right Cessation
- 1987-12-15 EP EP87202523A patent/EP0273512B1/de not_active Expired
- 1987-12-16 DK DK661387A patent/DK661387A/da not_active Application Discontinuation
- 1987-12-16 NZ NZ222938A patent/NZ222938A/en unknown
- 1987-12-16 PT PT86376A patent/PT86376B/pt unknown
- 1987-12-16 IE IE340787A patent/IE60698B1/en not_active IP Right Cessation
- 1987-12-17 JP JP62317662A patent/JPS63165329A/ja active Pending
- 1987-12-17 US US07/134,046 patent/US5026546A/en not_active Expired - Lifetime
1991
- 1991-02-28 GR GR91400170T patent/GR3001527T3/el unknown

Also Published As

Publication number	Publication date
US5026546A (en)	1991-06-25
DK661387A (da)	1988-06-20
IE873407L (en)	1988-06-19
PT86376A (en)	1988-01-01
IE60698B1 (en)	1994-08-10
PT86376B (pt)	1990-11-20
ES2037072T3 (es)	1993-06-16
EP0273512A2 (de)	1988-07-06
NZ222938A (en)	1990-11-27
GR3001527T3 (en)	1992-11-23
EP0273512B1 (de)	1991-02-27
DE3768232D1 (de)	1991-04-04
EP0273512A3 (en)	1988-07-27
DK661387D0 (da)	1987-12-16
JPS63165329A (ja)	1988-07-08

Publication	Publication Date	Title
ATE60999T1 (de)	1991-03-15	Dimethyldioctadecylammoniumbromid enthaltende stabilisierte adjuvanssuspension.
PT625053E (pt)	2002-09-30	Vacina a base de urease contra a infeccao por helicobacter
ATE137963T1 (de)	1996-06-15	Lh-rh-analoga enthaltende formulierungen
DK407587A (da)	1987-08-05	Transdermalt indgivelsessystem
DE3582118D1 (de)	1991-04-18	Waessrige emulsion eines acrylsaeurecopolymer.
BR8600840A (pt)	1986-11-11	Polimerizacao catalisada por oxianion
ATE82139T1 (de)	1992-11-15	Eine lipidloesliche substanz enthaltende waessrige fluessigkeit.
ATE93387T1 (de)	1993-09-15	Stabilisierung von vesikeln.
ES2130189T3 (es)	1999-07-01	Vacunas de virus sincitial respiratorio (rsv) mutante que contienen dicho virus y procedimientos de uso.
FI873083A (fi)	1988-10-25	Foerfarande foer odling av bordetella pertussis, kikhostatoxoid och kikhostavaccin.
IT1116840B (it)	1986-02-10	Perfezionamento nelle composizioni farmaceutiche contenenti prostaglandina
ATE37897T1 (de)	1988-10-15	Entfeuchtungszusammensetzung auf basis von fluorchlorkohlenwasserstoff, oberflaechenaktivem mittel und carbonsaeure.
DE3361138D1 (en)	1985-12-12	Ozone inactivated organisms as vaccines
DE3863492D1 (de)	1991-08-08	Stabile 5-fluorouracil-formulierungen.
FI873274A0 (fi)	1987-07-27	Tionofosfonsyraestrar.
ES2062044T3 (es)	1994-12-16	Un procedimiento para preparar un derivado de 2-oxoimidazolidina opticamente activo.
ATE52160T1 (de)	1990-05-15	Ethyl-n'-(methoxy(methylthio)phosphinyl)-n,ndimethyl-carbamidothioat.
DE3682380D1 (de)	1991-12-12	Stabilisiertes gossyplure und verfahren zu dessen herstellung.
SE7804124L (sv)	1979-10-13	Vaccinstabiliseringsmedel
GR24744B (el)	1963-06-18	Μεθοδος δια την παρασκευην εστερος του θειοφωσφορικου οξεος.

Legal Events

Date	Code	Title	Description
2008-03-15	EELA	Cancelled due to lapse of time